Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier is a research paper published in PLoS Biology (2023). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: UG3NS111689
National Institute of Mental Health
Grant: UG3MH120096
NIH Office of the Director
Grant: U42OD026645
National Institutes of Health
Grant: 1UG3NS111689-01
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system
National Institutes of Health
Grant: 1UG3MH120096-01
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.
National Institutes of Health
Grant: 1U42OD026645-01
BCM-Rice resource for the analysis of somatic gene editing in mice
FWCI
17.25
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords